SOUTH SAN FRANCISCO, Calif., Sept. 13, 2011 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, today announced that Eric Bjerkholt, Senior Vice President of Corporate Development & Finance and Chief Financial Officer, will be presenting at the upcoming UBS Global Life Sciences Conference on Tuesday, September 20, 2011 at 4:00 P.M. Eastern Time at the Grand Hyatt in New York City.
